Abstract Ginsenoside Rg1 (Rg1) is a major bioactive ingredient in Panax ginseng that has
low toxicity and has been shown to have neuroprotective effects. The objectives of the …

Ginsenoside Rb1 has been demonstrated to protect dopaminergic (DA) neurons from death
in vitro. However, the neuroprotective effects and underlying mechanism of Rb1 in treating …

Ginsenoside Rg1 is one of the most active ingredients in ginseng, which has been reported
to protect dopaminergic neurons and improve behavioral defects in MPTP model, 6-OHDA …

To date, no drug has been proven to be neuroprotective or disease‐modifying for
Parkinson's disease (PD) in clinical trials. Here, we aimed to assess preclinical evidence of …

Parkinson's disease is a chronic, multifactorial and progressive neurologic condition that
affects around six million people worldwide, normally over 60 years of age, and is …

Huntington's disease (HD) is one of main neurodegenerative diseases, characterized by
striatal atrophy, involuntary movements, and motor incoordination. Ginsenoside Rg1 (Rg1) …

Abstract Ginsenoside Rg3, extracted from Panax ginseng CA Meyer, has been shown to
possess neuroprotective properties. The present study aims to investigate the …

Background Ginsenosides are the main ingredients of Korean Red Ginseng. They have
extensively been studied for their beneficial value in neurodegenerative diseases such as …

In Parkinson's disease, neuroprotective therapy to rescue dopamine neurons has been
proposed. Ginsenoside Rg1, one of the biologically active ingredients of ginseng, may be a …

Ginsenoside Rg1, one of the biologically active ingredients of ginseng, has been considered
to be a candidate neuroprotective drug. The objective of the study was to study the protective …